Eudaimonia Partners, LLC Danaher Corp Transaction History

Eudaimonia Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$237.11 - $299.66 $27,030 - $34,161	114 Added 13.9%	934 $237,000
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $55,827 - $68,519	-217 Reduced 20.93%	820 $241,000
Q3 2021 Oct 25, 2021	BUY	$272.21 - $332.43 $17,149 - $20,943	63 Added 6.47%	1,037 $316,000
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $24,533 - $29,614	109 Added 12.6%	974 $261,000
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $22,299 - $25,819	105 Added 13.82%	865 $195,000
Q4 2020 Feb 18, 2021	BUY	$212.5 - $245.46 $4,250 - $4,909	20 Added 2.7%	760 $169,000
Q3 2020 Nov 23, 2020	BUY	$177.16 - $215.33 $131,098 - $159,344	740 New	740 $159,000
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $115,508 - $140,395	-652 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $63,062 - $86,646	-490 Reduced 42.91%	652 $115,000
Q1 2020 May 05, 2020	BUY	$121.39 - $169.05 $32,168 - $44,798	265 Added 30.22%	1,142 $158,000
Q4 2019 May 05, 2020	BUY	$133.47 - $153.48 $117,053 - $134,601	877 New	877 $135,000

2,525

550M

7.1M

5.14M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $150B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.